ArticleTheScientificWorldJournal2015
Adult Prevalence of Epilepsy in Spain: EPIBERIA, a Population-Based Study.
Article in TheScientificWorldJournal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04311151 (Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior (VICE)
Who cites it
14 citing papers in PubMed.
- [Knowledge of first aid for epileptic seizures among the general population and relatives of patients with epilepsy].Anales del sistema sanitario de Navarra · 2026Article
- "Epileptic seizure code in the region of Madrid": A process-based healthcare network for the acute management of epileptic seizures.Epilepsia open · 2026Article
- EPIDEP: Prevalence of undiagnosed depression in an epilepsy outpatient clinic.Epilepsy & behavior reports · 2025Article
- Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add study.Epilepsia open · 2025Observational
- Inflammatory Drug-Resistant Epilepsy Index (IDREI) as a Molecular Compound Biomarker in Focal Epilepsies.Biomolecules · 2025Observational
- Prevalence of active convulsive epilepsy in Dunukofia County in South East Nigeria: a door-to-door survey.Acta epileptologica · 2025Article
- Seizures, climate and pollution: is there evidence of an association?Frontiers in public health · 2025Article
- Prevalence of epilepsy in Morocco: A population-based study.Epilepsia open · 2023Article
- [Epilepsy and inequality: demographic description and analysis of the difficulty in accessing advanced resources in a population in a small health area].Revista de neurologia · 2023Observational
- Article
- Article
- An epidemiological survey of epilepsy in tropical rural areas of China.Epilepsia open · 2021Article
- Epilepsy lifetime prevalence in Iran: a large population- based national survey.Scientific reports · 2021Article
- Evaluation of Seizure Frequency Distribution in Epileptic Patients with Normal and Abnormal Electroencephalogram in Al-Zahra Hospital of Isfahan.Advanced biomedical research · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study assesses the lifetime and active prevalence of epilepsy in Spain in people older than 18 years.
methodsEPIBERIA is a population-based epidemiological study of epilepsy prevalence using data from three representative Spanish regions (health districts in Zaragoza, Almería, and Seville) between 2012 and 2013. The study consisted of two phases: screening and confirmation. Participants completed a previously validated questionnaire (EPIBERIA questionnaire) over the telephone.
resultsA total of 1741 valid questionnaires were obtained, including 261 (14.99%) raising a suspicion of epilepsy. Of these suspected cases, 216 (82.75%) agreed to participate in phase 2. Of the phase 2 participants, 22 met the International League Against Epilepsy's diagnostic criteria for epilepsy. The estimated lifetime prevalence, adjusted by age and sex per 1,000 people, was 14.87 (95% CI: 9.8-21.9). Active prevalence was 5.79 (95% CI: 2.8-10.6). No significant age, sex, or regional differences in prevalence were detected.
conclusionsEPIBERIA provides the most accurate estimate of epilepsy prevalence in the Mediterranean region based on its original methodology and its adherence to ILAE recommendations. We highlight that the lifetime prevalence and inactive epilepsy prevalence figures observed here were compared to other epidemiological studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.